Ralston SL, Lieberthal AS, Meissner HC et al (2014) Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134(5):e1474–e1502

Article  PubMed  Google Scholar 

Maraga NFSR Bronchiolitis: practice essentials, background, pathophysiology. Emedicine.medscape.com.2018. https://emedicine.medscape.com/article/961963-overview

Lin JA, Madikians A (2015) From bronchiolitis guideline to practice: a critical care perspective. World J Crit Care Med 4(3):152

Article  PubMed  PubMed Central  Google Scholar 

García García L, Korta Murua J, Callejón Callejón A (2017) Bronquiolitis aguda viral [Acute viral bronchiolitis]. Asociación Española de Pediatría 1:85–102

Google Scholar 

Ghazaly M, Nadel S (2018) Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatrics 177:913–920

Article  Google Scholar 

Hasegawa K, Tsugawa Y, Brown DFM et al (2013) Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics 132(1):28–36

Article  PubMed  PubMed Central  Google Scholar 

Guitart C, Bobillo-Perez S, Alejandre C et al (2022) Bronchiolitis, epidemiological changes during the SARS-CoV-2 pandemic. BMC Infect Dis 22:84

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hall CB, Weinberg GA, Iwane MK et al (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360(6):588–598

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hasegawa K, Pate BM, Mansbach JM et al (2015) Risk factors for requiring intensive care among children admitted to ward with bronchiolitis. Acad Pediatr 15(1):77

Article  PubMed  PubMed Central  Google Scholar 

Mansbach JM, Piedra PA, Stevenson MD et al (2012) Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics. ; 130(3)

Heppe Montero M, Gil-Prieto R, Walter S et al (2022) Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017. Hum Vaccin Immunother 18(1):1883379

Article  PubMed  Google Scholar 

Lieberthal AS, Bauchner H, Hall CB et al (2006) Diagnosis and management of bronchiolitis. Pediatrics 118(4):1774–1793

Article  Google Scholar 

Meissner HC (2016) Viral bronchiolitis in children. N Engl J Med 374:62–72

Article  PubMed  CAS  Google Scholar 

Chkhaidze I, Zirakishvili D (2017) Acute viral bronchiolitis in infants (review). Georgian Med News 264(264):43–50

Google Scholar 

Garegnani L, Styrmisdóttir L, Roson Rodriguez P et al (2021) Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev 11(11):CD013757

PubMed  Google Scholar 

Griffin MP, Yuan Y, Takas T et al (2020) Single-dose nirsevimab for prevention of RSV in preterm infants [published correction appears in N Engl J Med. ; 383(7):698]. N Engl J Med. 2020; 383(5):415–425

Hammitt LL, Dagan R, Yuan Y et al (2022) Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med 386(9):837–846

Article  PubMed  CAS  Google Scholar 

Muller WJ, Madhi SA, Seoane Nuñez B et al (2023) Nirsevimab for prevention of RSV in term and late-preterm infants. N Engl J Med 388(16):1533–1534

Article  PubMed  Google Scholar 

Simões EAF, Madhi SA, Muller WJ et al (2023) Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health 7(3):180–189

Article  PubMed  PubMed Central  Google Scholar 

Sun M, Lai H, Na F et al (2023) Monoclonal antibody for the prevention of respiratory syncytial virus in infants and children: a systematic review and network meta-analysis. JAMA Netw Open 6(2):e230023

Article  PubMed  PubMed Central  Google Scholar 

Drysdale SB, Cathie K, Flamein F et al (2023) Nirsevimab for prevention of hospitalizations due to RSV in infants. N Engl J Med 389(26):2425–2435

Article  PubMed  CAS  Google Scholar 

Francisco L, Cruz-Cañete M, Pérez C et al (2023) Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP). Pediatr (Engl Ed) 99(4):257–263

Google Scholar 

https://govern.cat/salapremsa/notes-premsa/566382/immunitzacio-contra-vrs-ha-reduit-77-percent-visites-urgencies-nadons-menors-6-mesos

Data obtained from the Conjunt minim basic dades, at https://catsalut.gencat.cat

Balaguer M, Alejandre C, Vila D et al (2017) Bronchiolitis score of Sant Joan De Déu: BROSJOD score, validation and usefulness. Pediatr Pulmonol 52(4):533–539

Article  PubMed  Google Scholar 

Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated pediatric risk of mortality score. Crit Care Med 24(5):743–752

Article  PubMed  CAS  Google Scholar 

Pollack MM, Patel KM, Ruttimann UE https://sivic.salut.gencat.cat/vrs

Lopez-Lacort M, Muñoz-Quiles C, Mira-Iglesias A et al (2024) Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024. Eurosurveillance ; 29(6)

Ernst C, Bejko D, Gaasch L et al (2024) Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg. Euro Surveill 29(4):pii–. https://doi.org/10.2807/1560-7917.ES.2024.29.4.2400033

Article  Google Scholar 

Kampmann B, Madhi SA, Munjal I et al (2023) Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med 388(16):1451–1464

Article  PubMed  CAS  Google Scholar 

Linssen RS, Teirlinck AC, van Boven M et al (2022) Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study. J Crit Care 68:165–168

Article  PubMed  Google Scholar 

De Luca D (2020) Managing neonates with respiratory failure due to SARS-CoV-2. Lancet Child Adolesc Health 4:e8. https://doi.org/10.1016/S2352-4642(20)30073-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kieffer A, Beuvelet M, Sardesai A et al (2022) Expected impact of universal immunization with nirsevimab against RSV-related outcomes and costs among all US infants in their first RSV season: a static model. J Infect Dis 226(Suppl 2):S282–S292

Article  PubMed  PubMed Central  Google Scholar